Trials / Unknown
UnknownNCT03150238
Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building
A Multicenter Prospective Cohort Study of Surgically Resected Crohn's Disease Patients Aiming to Identify Prognostic Factors for Re-operation: a New Score
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (estimated)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The project will consist of a multicentre, prospective, observational study with a total duration of 24 months. Clinical, endoscopic and ultrasound data will be collected in a dedicated database (on IG-IBD Register), which will be used to identify potential clinical, endoscopic and ultrasound risk factors of re-operation. These data could be merged into a shared score, to stratify patients according to the risk of post-surgical re- operation and to define an optimal therapeutic management in the post- operative period. Approximately 220 adult patients, with a defined diagnosis of CD, who underwent a surgery for CD in the previous 6 months will be enrolled.
Detailed description
Patients will be consecutively enrolled in this prospective cross-sectional study, during the first 12 months, and then followed for 12 (minimum) up to 24(maximum) months, depending on date of patients' enrolment (total study length: 2 years). Patients will be stratified according to risk factors and type of treatment carried out in that year
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observation of prognostic factors for relapse | The identification of the most relevant prognostic factors and the definition of their weight in predict the risk of re-intervention will be the basis for the definition of a combined score |
Timeline
- Start date
- 2017-04-13
- Primary completion
- 2019-01-31
- Completion
- 2019-05-31
- First posted
- 2017-05-12
- Last updated
- 2017-05-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03150238. Inclusion in this directory is not an endorsement.